<DOC>
	<DOCNO>NCT02710435</DOCNO>
	<brief_summary>The purpose study collect long term data Neovasc Reducer System subject refractory angina pectoris .</brief_summary>
	<brief_title>REDUCER-I : An Observational Study Neovasc Reducerâ„¢ System</brief_title>
	<detailed_description>This study multicenter , multi-country three-arm prospective retrospective investigation 400 subject conduct maximum 40 investigational center . Arm 1 include eligible prospective subject . Arm 2 include subject previously enrol treated Reducer COSIRA ( Coronary Sinus Reducer Treatment Refractory Angina ) study . Arm 3 include subject receive Reducer CE Mark ( unrelated COSIRA study ) .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>Inclusion Criteria ALL Arms : Subject inform study provide write informed consent prior enrollment Subject willing comply specify followup evaluation Inclusion Criteria Arm 1 : Symptomatic Coronary Artery Disease ( CAD ) chronic refractory angina pectoris despite attempted optimal medical therapy Subject limit treatment option revascularization Coronary Artery Bypass Grafting ( CABG ) Percutaneous Coronary Intervention ( PCI ) Evidence reversible myocardial ischemia Left Ventricular ejection fraction ( LVEF ) great equal 30 % Male nonpregnant female Inclusion Criteria Arm 2 : Subjects previously implant Reducer ( treatment ) arm COSIRA study Inclusion Criteria Arm 3 : Subjects Reducer implant CE Mark ( unrelated COSIRA study ) , prior enrollment ReducerI study Exclusion Criteria Arm 1 : Recent ( within three month ) acute coronary syndrome Recent ( within six month ) PCI CABG Unstable angina 30 day prior baseline Decompensated congestive heart failure ( CHF ) hospitalization due CHF three month prior baseline Life threaten rhythm disorder rhythm disorder would require placement internal defibrillator / pacemaker Severe chronic obstructive pulmonary disease ( COPD ) Subject undergo exercise tolerance test 6minute walk test reason refractory angina Severe valvular heart disease Subject pacemaker defibrillator electrode right atrium ( RA ) , right ventricle ( RV ) , Coronary Sinus ( CS ) Subject undergone tricuspid valve replacement repair Chronic renal failure include subject chronic hemodialysis Moribund subject , subject comorbidities limit life expectancy le one year Known allergy stainless steel nickel Currently enrol another device drug trial complete primary endpoint clinically interfere current study endpoint Angiographic Exclusion : Mean right atrial pressure great equal 15mmHg Subject anomalous abnormal CS demonstrate angiogram</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Coronary Sinus</keyword>
	<keyword>Reducer</keyword>
	<keyword>Refractory Angina</keyword>
	<keyword>Angina Pectoris</keyword>
	<keyword>Angina Pectoris , Stable</keyword>
	<keyword>Chronic Stable Angina</keyword>
	<keyword>Persistent Angina</keyword>
	<keyword>Neovasc Reducer System</keyword>
	<keyword>Refractory Angina Pectoris</keyword>
	<keyword>Coronary Sinus Narrowing</keyword>
	<keyword>Reversible Ischemic Heart Disease</keyword>
	<keyword>Chronic Angina</keyword>
	<keyword>End Stage Angina</keyword>
	<keyword>Coronary Sinus Reduction</keyword>
	<keyword>Coronary Sinus Reducer</keyword>
	<keyword>Chronic Refractory Angina</keyword>
	<keyword>Chronic Refractory Angina Pectoris</keyword>
</DOC>